Hegseth's testosterone plan for soldiers: risks still unclear
Pete Hegseth, US Secretary of Defense, has launched a testosterone-boosting initiative aimed at strengthening military readiness.
Medical and strategic risks—cardiovascular effects, behavioral changes, long-term health outcomes—remain largely unstudied in this military context.
Forbes examines whether performance gains justify the unknown liability exposure.